These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 19442776)

  • 1. Association between efficacy and body weight or body mass index for two low-dose oral contraceptives.
    Burkman RT; Fisher AC; Wan GJ; Barnowski CE; LaGuardia KD
    Contraception; 2009 Jun; 79(6):424-7. PubMed ID: 19442776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bleeding patterns with monophasic and triphasic low-dose ethinyl estradiol combined oral contraceptives.
    Hampton RM; Zhang HF; Barnowski C; Wan GJ
    Contraception; 2008 Jun; 77(6):415-9. PubMed ID: 18477490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of low-dose oral contraceptives on body weight: results of a randomized study of up to 13 cycles of use.
    Burkman RT; Fisher AC; LaGuardia KD
    J Reprod Med; 2007 Nov; 52(11):1030-4. PubMed ID: 18161401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body weight does not impact pregnancy rates during use of a low-dose extended-regimen 91-day oral contraceptive.
    Westhoff CL; Hait HI; Reape KZ
    Contraception; 2012 Mar; 85(3):235-9. PubMed ID: 22067763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scheduled and unscheduled bleeding patterns with two combined hormonal contraceptives: application of new recommendations for standardization.
    Hampton RM; Fisher AC; Pagano S; LaGuardia KD
    Fertil Steril; 2009 Aug; 92(2):434-40. PubMed ID: 18930189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body mass index, weight, and oral contraceptive failure risk.
    Holt VL; Scholes D; Wicklund KG; Cushing-Haugen KL; Daling JR
    Obstet Gynecol; 2005 Jan; 105(1):46-52. PubMed ID: 15625141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of body weight in oral contraceptive failure: results from the 1995 national survey of family growth.
    Brunner LR; Hogue CJ
    Ann Epidemiol; 2005 Aug; 15(7):492-9. PubMed ID: 16029841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 micro g (Loestrin 24 Fe).
    Nakajima ST; Archer DF; Ellman H
    Contraception; 2007 Jan; 75(1):16-22. PubMed ID: 17161118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical comparison of triphasic norgestimate/35 micrograms ethinyl estradiol and monophasic norethindrone acetate/20 micrograms ethinyl estradiol. Cycle control, lipid effects, and user satisfaction.
    Sulak P; Lippman J; Siu C; Massaro J; Godwin A
    Contraception; 1999 Mar; 59(3):161-6. PubMed ID: 10382078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of standard and low dose 17beta-estradiol plus norethisterone acetate on body composition and leptin in postmenopausal women at risk of body mass index and waist girth related cardiovascular and metabolic disease.
    Odabasi AR; Yuksel H; Karul A; Kozaci D; Sezer SD; Onur E
    Saudi Med J; 2007 Jun; 28(6):855-61. PubMed ID: 17530099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy.
    Ylikorkala O; Lim P; Caubel P
    Clin Ther; 2000 May; 22(5):622-36. PubMed ID: 10868559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter randomized comparative trial of two low-dose triphasic combined oral contraceptives containing desogestrel or norethindrone.
    Shoupe D
    Obstet Gynecol; 1994 May; 83(5 Pt 1):679-85. PubMed ID: 8164925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body mass index does not affect the efficacy or bleeding profile during use of an ultra-low-dose combined oral contraceptive.
    Nakajima ST; Pappadakis J; Archer DF
    Contraception; 2016 Jan; 93(1):52-7. PubMed ID: 26410176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous, daily levonorgestrel/ethinyl estradiol vs. 21-day, cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trial.
    Teichmann A; Apter D; Emerich J; Greven K; Klasa-Mazurkiewicz D; Melis GB; Spaczynski M; Grubb GS; Constantine GD; Spielmann D
    Contraception; 2009 Dec; 80(6):504-11. PubMed ID: 19913143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with a new norgestimate-containing oral contraceptive.
    Huber J
    Int J Fertil; 1991; 36 Suppl 1():25-31. PubMed ID: 1678378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of body composition during low-dose estrogen oral contraceptives treatment.
    Franchini M; Caruso C; Nigrelli S; Poggiali C
    Acta Eur Fertil; 1995; 26(2):69-73. PubMed ID: 9098463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations.
    Pomp ER; le Cessie S; Rosendaal FR; Doggen CJ
    Br J Haematol; 2007 Oct; 139(2):289-96. PubMed ID: 17897305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of two combined oral contraceptives containing ethinyl estradiol 30 microg combined with either gestodene or drospirenone on hemostatic parameters, lipid profiles and blood pressure.
    Yildizhan R; Yildizhan B; Adali E; Yoruk P; Birol F; Suer N
    Arch Gynecol Obstet; 2009 Aug; 280(2):255-61. PubMed ID: 19125264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.